Amyloid deposition, hypometabolism, and longitudinal cognitive decline - Wikidata - awgldk - TriplyDB

Amyloid deposition, hypometabolism, and longitudinal cognitive decline

Amyloid deposition, hypometabolism, and longitudinal cognitive decline

http://www.wikidata.org/entity/Q37207254

about

18 F-FDG PET for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI)Metabolic Alterations Associated to Brain Dysfunction in Diabetes The Alzheimer's Disease Neuroimaging Initiative phase 2: Increasing the length, breadth, and depth of our understanding The Alzheimer's Disease Neuroimaging Initiative 2 PET Core: 2015 The relevance of beta-amyloid on markers of Alzheimer's disease in clinically normal individuals and factors that influence these associations Cerebrospinal fluid analysis detects cerebral amyloid-β accumulation earlier than positron emission tomography Prediction of Alzheimer's disease pathophysiology based on cortical thickness patterns Imago Mundi, Imago AD, Imago ADNI Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers Tauopathy PET and amyloid PET in the diagnosis of chronic traumatic encephalopathies: studies of a retired NFL player and of a man with FTD and a severe head injury.Understanding cognitive deficits in Alzheimer's disease based on neuroimaging findings A focus on structural brain imaging in the Alzheimer's disease neuroimaging initiative Practice effects and amyloid deposition: preliminary data on a method for enriching samples in clinical trials.Diagnostic accuracy and practice effects in the National Alzheimer's Coordinating Center Uniform Data Set neuropsychological battery.A data-driven model of biomarker changes in sporadic Alzheimer's disease.2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.Evolving Evidence for the Value of Neuroimaging Methods and Biological Markers in Subjects Categorized with Subjective Cognitive Decline.Amyloid burden and neural function in people at risk for Alzheimer's Disease.Comparison of CSF markers and semi-quantitative amyloid PET in Alzheimer's disease diagnosis and in cognitive impairment prognosis using the ADNI-2 database.Amyloid and APOE ε4 interact to influence short-term decline in preclinical Alzheimer disease.Time to Amyloid Positivity and Preclinical Changes in Brain Metabolism, Atrophy, and Cognition: Evidence for Emerging Amyloid Pathology in Alzheimer's Disease Conversion Discriminative Analysis on Mild Cognitive Impairment Using Multiple Cortical Features from MR Images.18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons.Amyloid PET imaging in Alzheimer's disease: a comparison of three radiotracers.Cerebral Blood Flow and Amyloid-β Interact to Affect Memory Performance in Cognitively Normal Older Adults.Prediction of Conversion to Alzheimer's Disease with Longitudinal Measures and Time-To-Event Data.Is verbal episodic memory in elderly with amyloid deposits preserved through altered neuronal function?Amyloid burden, neuronal function, and cognitive decline in middle-aged adults at risk for Alzheimer's disease Cholinergic basal forebrain atrophy predicts amyloid burden in Alzheimer's disease.An abnormal resting-state functional brain network indicates progression towards Alzheimer's disease.Diagnostic accuracy of CSF Ab42 and florbetapir PET for Alzheimer's disease Florbetapir F 18 amyloid PET and 36-month cognitive decline: a prospective multicenter study.The preclinical Alzheimer cognitive composite: measuring amyloid-related decline Biomarkers and cognitive endpoints to optimize trials in Alzheimer's disease.Early detection of Alzheimer's disease using PiB and FDG PET Mapping 3-year changes in gray matter and metabolism in Aβ-positive nondemented subjects.Language Experience Changes Language and Cognitive Ability Biomarker progressions explain higher variability in stage-specific cognitive decline than baseline values in Alzheimer disease Molecular imaging of Alzheimer disease pathology The mediational effects of FDG hypometabolism on the association between cerebrospinal fluid biomarkers and neurocognitive function

P2860

Q24186399-0973BF7D-6265-4357-88DA-D9B56C743B35 Q26783376-CE72403F-2513-40FA-94B9-981916C788F5 Q26801640-39A4F081-5571-4DDC-A3F4-344E31AF54FE Q26801654-929FDF66-D7CE-44D4-AF8C-51F826C56AC5 Q26830467-2760D003-2BA4-423C-ACFB-17EB1B2736F7 Q28273817-1D154518-5EB0-454C-9B1D-C48344505AB4 Q28602247-13790667-B922-4A64-9F26-8285F6AC58BE Q28650395-468CF86A-5068-4B68-9012-77AC4CAB035B Q29620245-91431D61-C3FE-4BE0-B649-CB0DF600F35F Q30409615-7BC199C9-09F4-4514-834A-8838AB3099D9 Q30666527-D499B5C2-5D33-4972-B769-376D5FB6D326 Q30724134-A2B75830-A448-4455-9F94-7D708BAADBB3 Q30774130-C73ECA36-7320-401C-9F77-241CEA55D87D Q30783499-648FFEE8-B3D7-48E4-A79C-37D02EF35DCC Q30835966-3024F7D8-0D95-429A-992C-46D6B4EDF9DC Q30971403-A8B67406-F49F-43DC-B487-B8B58BE45340 Q30996727-2F370610-7ED6-43C8-A79F-F8631F7D85CB Q33599047-973E644A-DC58-4991-B6F3-BCE664E6E780 Q33604453-EE3A5358-1174-43F1-ABC1-9B5661ADDD15 Q33672569-8BEEAC30-602C-4987-9EC7-A9BC5D90B8E5 Q33695122-9DACF34D-E664-46E0-ABD2-E31903D60EDA Q33701135-6C966D86-5A8C-438A-AB8B-4FCE3294B371 Q33740879-0E0E8E91-44C8-4E0D-A09E-3BCCEF50B879 Q33747987-FD3A9002-D620-420F-9110-433CC69CF3E4 Q33775095-21C384EC-9944-4231-9162-E0CF7F7B59D6 Q33816135-627B30A2-A559-418D-ACED-D626BDDA8B20 Q33872248-C6F3F615-6ADA-4427-AF1D-5365A89F6FD7 Q33920450-988DF3A4-859C-458C-B093-7477B8131773 Q33998690-F566543D-2FD1-4621-8DC2-15E461F682A9 Q34095084-CFA5B77C-AF0F-4339-A006-561BBB99C6BA Q34286393-91149229-7B09-4598-9CE1-666F4636CA83 Q34333511-C35DB4F9-F2EA-46C0-8CB6-231C939F1B2C Q34422469-27F35BCA-8844-445D-8482-D5021C61AC1A Q34477459-249660A6-B1BE-45D2-9A18-5F731AA3FF49 Q34483878-9FD0A71D-9031-4B5C-BD3F-387A70B81350 Q34498348-37E853F9-ED4C-468A-A280-B7BFE2A07920 Q34568570-413D4AB8-C1C5-4BE9-BDFC-5E37E662EB65 Q34620948-A8B6D762-9EEE-49BB-8BF9-546B4BE7859E Q34651135-22F488D7-DC30-4236-B03D-D5E32AA5A9C5 Q34674417-CFA8FEEE-58DC-4480-BAA8-F2F501CD5701

P2860

Amyloid deposition, hypometabolism, and longitudinal cognitive decline

http://www.wikidata.org/entity/Q37207254

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on October 2012

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Amyloid deposition, hypometabolism, and longitudinal cognitive decline

@en

Amyloid deposition, hypometabolism, and longitudinal cognitive decline.

@nl

type

label

Amyloid deposition, hypometabolism, and longitudinal cognitive decline

@en

Amyloid deposition, hypometabolism, and longitudinal cognitive decline.

@nl

prefLabel

Amyloid deposition, hypometabolism, and longitudinal cognitive decline

@en

Amyloid deposition, hypometabolism, and longitudinal cognitive decline.

@nl

P1433

Q37207254-FAEC7092-07E3-4873-871F-B4092932BF2D

P1476

Q37207254-9AE8AC11-B88D-4805-968C-3E4FF6B98086

P2093

Q37207254-657D0EDA-4CB9-4517-BA60-B9E5D2F5BBB1

Q37207254-7A2C8BF3-D25D-4D83-98C6-2920A621B8FE

Q37207254-81B3615C-97BE-41FD-95DE-4E1EE4007CAB

Q37207254-C9281E2C-2827-42A0-97C8-FC1839CF9601

P2860

Q37207254-034967D3-AAD3-4BA7-B485-A9E19FBC34AA

Q37207254-0543EB38-EAD8-468A-85F3-473385931707

Q37207254-09138D60-6ACC-4C77-945F-50C0F9498C5E

Q37207254-0C3CE123-A535-4CFA-835C-7DC228CD99DA

Q37207254-14464171-4C12-4451-BBAF-B1C6C02AFD7C

Q37207254-226330EB-C01C-49DB-BBBA-D18E03572525

Q37207254-247753E0-8803-417A-AAB8-1021885CD05F

Q37207254-2AF66AE6-42B5-4AB5-A8BB-0456BE9F7B91

Q37207254-3072F447-F31A-4855-A5BF-C5936E0BB9E7

Q37207254-3B1296A6-2F5A-4C48-9503-0F5CABD50709

P304

Q37207254-7952B1FE-F7DA-4C09-978C-122A46581873

P31

Q37207254-6C61795D-620B-4092-901C-19D640F2F9C0

P356

Q37207254-FBDBBB6A-3088-45F0-A439-4F330A717B96

P433

Q37207254-01F4D13F-D9CF-47C7-BC4E-10C931BF79B6

P478

Q37207254-36D742BD-D125-4BC9-A5B2-C2C38F72CF29

P50

Q37207254-2A8B9FAD-E49A-47B5-A213-8017FE4D1D0C

Q37207254-37315139-70B8-45F1-8BE3-A08C6B5BE98A

Q37207254-491D5034-48A1-4699-B605-15E35D1A9A6A

Q37207254-C12DB58B-96E7-473D-9F54-09DBFF37209D

Q37207254-C1A08F19-DF86-4464-B21B-E9AC1C7C95C9

P577

Q37207254-88328A58-965D-4B8C-8180-B4C0B6A54299

P698

Q37207254-CBFF29A0-6CEA-4172-B2CE-EEF7F1D3183D

P932

Q37207254-31325D16-D07D-4D2E-B261-964ECA4A30CA

P356

P1433

Annals of Neurology

P1476

Amyloid deposition, hypometabolism, and longitudinal cognitive decline

@en

P2093

Abhinay D Joshi

http://www.w3.org/2001/XMLSchema#string

Robert A Koeppe

http://www.w3.org/2001/XMLSchema#string

Susan M Landau

http://www.w3.org/2001/XMLSchema#string

William J Jagust

http://www.w3.org/2001/XMLSchema#string

P2860

Use of Florbetapir-PET for Imaging β-Amyloid Pathology

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

Unified segmentation

Diagnosis of Alzheimer's disease in a community hospital-based brain bank program.

Conversion of amyloid positive and negative MCI to AD over 3 years: an 11C-PIB PET study.

Longitudinal cognitive decline is associated with fibrillar amyloid-beta measured by [11C]PiB

Cognition and beta-amyloid in preclinical Alzheimer's disease: data from the AIBL study.

Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI.

P304

578-586

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ANA.23650

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

72

http://www.w3.org/2001/XMLSchema#string

P50

Alzheimer's Disease Neuroimaging Initiative

Ronald C. Petersen

Michael W. Weiner

P577

2012-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23109153

http://www.w3.org/2001/XMLSchema#string

P932

3786871

http://www.w3.org/2001/XMLSchema#string